Statsautoriseret fodterapeut BClear ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
Estimate generation in progress, please wait...
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Bankruptcy risk for industry  0.8% 0.8% 0.8% 0.8% 0.8%  
Bankruptcy risk  8.4% 5.9% 4.6% 2.9% 3.7%  
Credit score (0-100)  31 39 44 58 51  
Credit rating  B BB BB BB BB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Net sales  0 0 0 0 0  
Gross profit  533 79.2 67.5 280 488  
EBITDA  51.7 1.4 2.5 37.8 46.8  
EBIT  51.7 1.4 2.5 27.0 -4.7  
Pre-tax profit (PTP)  50.9 0.2 1.7 26.8 -4.7  
Net earnings  39.1 -0.1 1.1 20.6 0.1  
Pre-tax profit without non-rec. items  50.9 0.2 1.7 26.8 -4.7  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Tangible assets total  0.0 0.0 0.0 117 164  
Shareholders equity total  43.0 42.8 43.9 64.5 64.6  
Interest-bearing liabilities  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  182 124 154 193 273  

Net Debt  -182 -123 -147 -42.9 -43.7  
 
See the entire balance sheet

Volume 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  533 79.2 67.5 280 488  
Gross profit growth  0.0% -85.1% -14.8% 314.9% 74.3%  
Employees  1 1 1 1 1  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  182 124 154 193 273  
Balance sheet change%  0.0% -31.7% 24.1% 25.3% 41.2%  
Added value  51.7 1.4 2.5 27.0 46.8  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 107 -5  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  1.0 2.0 3.0 4.0 -1.0  

Profitability 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  9.7% 1.8% 3.6% 9.7% -1.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  28.4% 0.9% 1.8% 15.6% -2.0%  
ROI %  120.5% 3.3% 5.7% 47.3% -6.8%  
ROE %  91.0% -0.3% 2.5% 37.9% 0.2%  

Solidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Equity ratio %  23.6% 34.5% 28.5% 33.4% 23.7%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -351.9% -8,621.0% -5,956.0% -113.5% -93.6%  
Gearing %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 0.0% 0.0%  

Liquidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Quick Ratio  2.2 1.5 1.4 0.6 0.4  
Current Ratio  2.2 1.5 1.4 0.6 0.4  
Cash and cash equivalent  182.1 123.2 146.5 42.9 43.7  

Capital use efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  161.3 42.8 43.9 -47.1 -128.6  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales / employee  0 0 0 0 0  
Added value / employee  52 1 2 27 47  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  52 1 2 38 47  
EBIT / employee  52 1 2 27 -5  
Net earnings / employee  39 -0 1 21 0